Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency

Table 2 Immunodeficiencies among 101 COVID-19 survey respondents

Type of primary immunodeficiency disorder	Percentage (%)	Responses^*
Common variable immunodeficiency (CVID)	72.3	73
Hypogammaglobulinemia	10.9	11
Immunoglobulin deficiency (IgA, IgA1, IgG, IgG2, IgG3, IgM)	6.9	7
STAT1 deficiency	2.0	2
B cell dysfunction	1.0	1
Chronic lymphocytic leukemia (CLL)	1.0	1
IPEX syndrome	1.0	1
Severe combined immunodeficiency disease (SCID) Omenn Syndrome RAG1	1.0	1
Secondary hypoglobulinemia	1.0	1
Secondary immunodeficiency	1.0	1
HLA-B27 autoimmune disease	1.0	1
Dysgammaglobulinemia	1.0	1

Data from COVID-19 Vaccine Hesitancy Survey in Primary Immunodeficiency Patients, March 24 to April 7, 2021
^*Three non-specific responses were excluded from the estimations
CLL chronic lymphocytic leukemia, CVID common variable immunodeficiency, HLA-B27 human leukocyte antigen B27, Ig immunoglobulin, IPEX immunodysregulation polyendocrinopathy enteropathy X-linked, RAG1 recombination activating 1 gene, SCID severe combined immunodeficiency disease, STAT1 signal transducer and activator of transcription 1

ISSN: 1710-1492